Main menu

NCM 2023 Houston: GoT-Splice: unraveling cell-type-specific impact of splicing factor mutations


RNA splicing factors are recurrently mutated in blood diseases, but their impact on hematopoiesis remains unclear. The study of splicing factor mutations has been technologically challenging. To overcome such limitations, we integrated genotyping of transcriptomes (GoT) with long-read single-cell transcriptomics and proteo-genomics for single-cell profiling of transcriptomes, surface proteins, somatic mutations, and RNA splicing (GoT-Splice). We applied GoT-Splice to hematopoietic progenitors from myelodysplastic syndrome (MDS) patients with mutations in the core splicing factor SF3B1 as well as clonal hematopoiesis samples (CH). In both conditions, we observed an erythroid bias and cell-type-specific cryptic 3′ splice site usage in SF3B1 mutant cells. Collectively, our work demonstrated the conserved mechanisms of mutational impact profiled directly in human samples.

Authors: Mariela Cortés López

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag